Peripherally Restricted Cannabinoids for the Treatment of Pain (Q38615325)

4 September 2017

Peripherally Restricted Cannabinoids for the Treatment of Pain (English)

1 reference

4 September 2017

0 references

E Alfonso Romero-Sandoval

1

1 reference

4 September 2017

Scott Asbill

2

1 reference

4 September 2017

Candler A Paige

3

1 reference

4 September 2017

Kiara Byrd-Glover

4

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 October 2015

1 reference

4 September 2017

1 reference

4 September 2017

35

1 reference

4 September 2017

10

1 reference

4 September 2017

917-925

1 reference

Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008.

4 September 2017

1 reference

The pharmacologic and clinical effects of medical cannabis.

21 January 2018

1 reference

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

21 January 2018

1 reference

Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury

21 January 2018

1 reference

Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users

21 January 2018

1 reference

Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers

21 January 2018

1 reference

Molecular mechanisms of cannabinoid addiction

21 January 2018

1 reference

Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine

21 January 2018

1 reference

Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons

21 January 2018

1 reference

Functional interactions between endogenous cannabinoid and opioid systems: focus on alcohol, genetics and drug-addicted behaviors.

21 January 2018

1 reference

Pharmacological and biochemical interactions between opioids and cannabinoids.

21 January 2018

1 reference

Drug wanting: behavioral sensitization and relapse to drug-seeking behavior

21 January 2018

1 reference

Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats

21 January 2018

1 reference

The effect of chronic opioid vs. cannabinoid exposure on the expression of tolerance to morphine- or WIN-55,212-2-induced analgesia and hypothermia in the guinea pig.

21 January 2018

1 reference

Cannabinoid-opioid interaction in chronic pain

21 January 2018

1 reference

Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions

21 January 2018

1 reference

The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells

21 January 2018

1 reference

Endocannabinoids limit excessive mast cell maturation and activation in human skin

21 January 2018

1 reference

Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis.

21 January 2018

1 reference

Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts.

21 January 2018

1 reference

Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment

21 January 2018

1 reference

Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis

21 January 2018

1 reference

Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitis.

21 January 2018

1 reference

CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain

21 January 2018

1 reference

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

21 January 2018

1 reference

An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis

21 January 2018

1 reference

Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy

21 January 2018

1 reference

JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy

21 January 2018

1 reference

Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons.

21 January 2018

1 reference

Cannabinoid modulation of cutaneous Adelta nociceptors during inflammation

21 January 2018

1 reference

Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain

21 January 2018

1 reference

The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer pain

21 January 2018

1 reference

Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration

21 January 2018

1 reference

Ajulemic acid: A novel cannabinoid produces analgesia without a "high"

21 January 2018

1 reference

Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists.

21 January 2018

1 reference

Activation and Binding of Peroxisome Proliferator-Activated Receptor γ by Synthetic Cannabinoid Ajulemic Acid

21 January 2018

1 reference

Complementary and alternative medical therapies in multiple sclerosis--the American Academy of Neurology guidelines: a commentary

21 January 2018

1 reference

A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain

21 January 2018

1 reference

Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.

21 January 2018

1 reference

In vitro/in vivo correlation studies for transdermal delta 8-THC development

21 January 2018

1 reference

Cannabinoid agonists attenuate capsaicin-induced responses in human skin

21 January 2018

1 reference

Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal delta9-tetrahydrocannabinol

21 January 2018

1 reference

Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model

21 January 2018

1 reference

Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes

21 January 2018

1 reference

Transdermal permeation of WIN 55,212-2 and CP 55,940 in human skin in vitro

21 January 2018

1 reference

Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2Cannabinoid Receptors

21 January 2018

1 reference

Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors

21 January 2018

1 reference

Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PHAR.1642

1 reference

4 September 2017

1 reference